Clinical trial

A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.

NCT07496177

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention HTD1801 Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-09

PhasePHASE2

Conditions

T2DMverified · MONDO: type 2 diabetes mellitus

CKDunresolved

Interventions

HTD1801DRUG

placeboOTHER

Sponsors & collaborators

Institute of Medicinal Biotechnology, Chinese Academy of Medical Scienceslead sponsor

Weifang People's Hospitalcollaborator

Shenzhen HighTide Biopharmaceutical Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07496177 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.